Back

Correction to: Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine

European Heart Journal

27 February 2025
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
A novel 3D in vitro model of cardiac transthyretin amyloidosis to investigate amyloid kinetics
28 August 2026
thumbnail
Congress Presentation
Transthyretin amyloid cardiomyopathy: a 2-year single-centre experience
29 August 2022
thumbnail
Congress Session
ATTR cardiomyopathy: from current practices to future treatment and monitoring
17 May 2025
thumbnail
Congress Presentation
Evaluating diagnostic scoring systems for early detection of transthyretin amyloidosis in patients with HFpEF and left ventricular hypertrophy
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources